Revance Therapeutics | 부채

Debt 변화 날짜
AbbVie USD 60.75B 269M 2023-09
ALKERMES USD 291.37M 635K 2023-09
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Eli Lilly USD 20.17B 1.35B 2023-09
Merck USD 34.86B 2.05B 2023-09
Neurocrine Biosciences USD 169.9M 200K 2023-09
Pacira USD 522.44M 2.14M 2023-12
Supernus Pharmaceuticals USD 480.86M 78.9M 2023-03



Revance Therapeutics 부채 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.